TCOYD

What TCOYD does

TCOYD (Taking Control Of Your Diabetes) is a 501(c)(3) nonprofit diabetes education and "edutainment" organization founded in 1995 and headquartered in Solana Beach, California. It educates and motivates people with diabetes (Type 1, Type 2, and other forms) to take a more active role in managing their condition, and provides accredited continuing education to the medical professionals who treat them. The organization was founded by Dr. Steven V. Edelman, an endocrinologist who himself lives with Type 1 diabetes, and its faculty includes Dr. Jeremy H. Pettus, Dr. Tricia Santos Cavaiola, Dr. Schafer Boeder, and Dr. William H. Polonsky.

TCOYD's core technology is a multi-format content platform rather than software. The central hub at tcoyd.org distributes a Video Vault of educational videos, the "TCOYD The Podcast" (hosted on Transistor FM and syndicated to Apple Podcasts and Spotify), a monthly newsletter, blog articles, downloadable infographics, and recipes. Signature live and virtual events include the annual ONE Conference (ONE 2026 scheduled August 14-16) and Virtual Diabetes Jeopardy, an online game-show educational format. Original diabetes-themed songs are published on Spotify and Apple Music. For healthcare professionals, TCOYD offers accredited CME/CE programs covering continuous ketone monitoring and CGM interpretation. An Access Page provides diabetes care navigation resources covering insurance, medication savings, and device assistance. The underlying technical stack is described as conventional content publishing, with no proprietary software product, API, or mobile application.

The business model is sponsorship- and donation-funded rather than transactional. Revenue derives from tiered corporate sponsorships (Platinum: MannKind and Sanofi; Gold: Dexcom, Eli Lilly, Medtronic; Silver: Abbott/FreeStyle Libre, Bayer, Madrigal, Vertex; Supporting: Novo Nordisk, Xeris, Eversense, Insulet, Genentech) and individual charitable donations processed via Donorbox. All patient-facing content, podcasts, videos, and events are free; HCP-facing CME/CE courses carry CEU accreditation but pricing is not publicly disclosed. The organization operates primarily in the USA but distributes content globally through digital channels, and has a registered trademark on "Taking Control Of Your Diabetes."

Name

TCOYD

Legal name

Taking Control Of Your Diabetes

Website

https://tcoyd.org

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

1–10 employees

Short description

TCOYD is a 501(c)(3) nonprofit founded in 1995 that delivers free diabetes education and edutainment content — videos, podcast, newsletter, events, and original songs — to people with diabetes, plus accredited CME/CE programs to healthcare professionals, funded by pharma and device sponsorships.

Ownership category

akta.pro rank

Product category

Diabetes Patient Education

NAICS

Educational Support Services (61171), Broadcasting and Content Providers (516)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Special Education & Accessibility-Optimized Media (UDL, AAC, Captioning) (EDAGALAH)

akta.pro secondary industries

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ)

Keywords

• Diabetes education
• Continuing medical education
• Patient education programs
• Healthcare professional training
• Chronic disease management

Headquarters

HQ city

Solana Beach

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Sponsorships and Grants: TCOYD receives financial support from pharmaceutical and medical device companies including MannKind, Sanofi, Dexcom, Lilly, Medtronic, Bayer, Abbott (FreeStyle Libre), Madrigal, Vertex, and others. These sponsorships fund educational content and programs.
2. Donations: As a 501(c)(3) nonprofit organization, TCOYD accepts charitable donations from individuals and organizations to support its mission of diabetes education.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

TCOYD is a 501(c)(3) nonprofit diabetes education organization that delivers free, multi-channel edutainment content—including podcasts, videos, newsletters, articles, original songs, and signature events (ONE Conference and Virtual Diabetes Jeopardy)—to people with diabetes and their families. It also provides accredited CME/CE continuing education programs (e.g., continuous ketone monitoring, CGM interpretation) for healthcare professionals who treat diabetes.

Product overview

TCOYD (Taking Control Of Your Diabetes) is a nonprofit diabetes edutainment organization that provides a comprehensive ecosystem of educational resources for people with diabetes and healthcare professionals. The core offering is the TCOYD Website and Platform, which serves as the central hub for all content distribution. Supporting products include the TCOYD Podcast for audio-based education, the Video Vault for on-demand video content, and the Monthly Newsletter for regular updates. TCOYD also hosts signature events including the annual ONE Conference and Virtual Diabetes Jeopardy for interactive learning. For healthcare professionals, TCOYD offers accredited CME/CE Programs covering topics like continuous ketone monitoring and CGM interpretation. The Access Page provides diabetes care navigation resources including insurance guidance and medication savings programs. The organization also creates TCOYD Original Songs for diabetes education. TCOYD is primarily a content and education platform, not a technology or software product.

Differentiator

Problem solved

Functional benefit

Brands

• TCOYD The Podcast: The official podcast of Taking Control Of Your Diabetes featuring discussions on diabetes management, technology, medications, and patient stories
• ONE Conference
• Virtual Diabetes Jeopardy

Products and services

• TCOYD Website and Platform Central online hub providing free diabetes education through videos, podcasts, articles, newsletters, recipes, infographics, and interactive resources for people with diabetes and healthcare professionals.
• TCOYD Podcast Audio podcast series providing diabetes education, expert interviews, patient stories, and discussions on diabetes management, technology, medications, and research for the diabetes community.
• Video Vault Comprehensive on-demand video library containing educational content on diabetes topics including medications, devices, complications, lifestyle management, and original songs.
• TCOYD Monthly Newsletter Regular monthly email newsletter providing diabetes news, educational content, and updates on the latest diabetes research and treatments.
• ONE Conference Annual diabetes education conference featuring expert speakers, workshops, exhibitor hall, and networking opportunities for people with diabetes and healthcare professionals.
• Virtual Diabetes Jeopardy Interactive online educational event using a game-show format to teach diabetes knowledge in an engaging, entertaining way.
• CME/CE Programs for Healthcare Professionals Accredited continuing medical education programs for healthcare providers covering diabetes management, including courses on continuous ketone monitoring and CGM data interpretation.
• Access Page - Diabetes Care Navigation Resource hub providing information on insurance navigation, medication savings programs, device assistance, and resources for accessing diabetes supplies and care.
• TCOYD Original Songs Original music created by TCOYD to educate and inspire the diabetes community, available on Spotify and Apple Music, with music videos in the Video Vault.

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

14 partnerships are on record, tiered flagship/platinum, core/gold, core/silver and supporting.

• MannKindflagship/platinumGTM or Marketing PartnerPlatinum sponsor of TCOYD. MannKind manufactures Afrezza (inhaled insulin) and partnered with TCOYD on educational content about inhaled insulin options for people with diabetes.
• Sanofiflagship/platinumGTM or Marketing PartnerPlatinum sponsor of TCOYD. Sanofi manufactures insulin products (Admelog, Apidra, Lantus, Toujeo) and other diabetes medications.
• Dexcomcore/goldGTM or Marketing PartnerGold sponsor of TCOYD. Dexcom manufactures continuous glucose monitors (G6, G7) and partnered on educational content about CGM technology.
• Eli Lilly and Companycore/goldGTM or Marketing PartnerGold sponsor of TCOYD. Lilly manufactures insulin products (Basaglar, Humalog, Lyumjev), GLP-1 medications (Mounjaro, Trulicity), and other diabetes therapies.
• Medtroniccore/goldGTM or Marketing PartnerGold sponsor of TCOYD. Medtronic manufactures insulin pumps and diabetes management technology.
• Abbott (FreeStyle Libre)core/silverGTM or Marketing PartnerSilver sponsor of TCOYD. Abbott manufactures FreeStyle Libre continuous glucose monitoring systems and partnered on content about CGM technology for Type 2 diabetes.
• Bayercore/silverGTM or Marketing PartnerSilver sponsor of TCOYD. Bayer manufactures Kerendia (finerenone) for diabetic kidney disease and partnered on educational content about cardio-kidney-metabolic connection in diabetes.
• Madrigal Pharmaceuticalscore/silverGTM or Marketing PartnerSilver sponsor of TCOYD. Madrigal manufactures Rezdiffra (resmetirom) for MASH/NASH liver disease and partnered on content about fatty liver disease and diabetes.
• Vertex Pharmaceuticalscore/silverGTM or Marketing PartnerSilver sponsor of TCOYD. Vertex is developing VX-880 and VX-264 stem cell-derived islet cell therapies for Type 1 diabetes. TCOYD provides education about islet cell transplantation research and clinical trials.
• Novo NordisksupportingGTM or Marketing PartnerSupporting sponsor of TCOYD. Novo Nordisk manufactures insulin products (Fiasp, Levemir, NovoLog, Tresiba), GLP-1 medications (Ozempic, Wegovy, Rybelsus), and glucagon (Zegalogue).
• Xeris PharmaceuticalssupportingGTM or Marketing PartnerSupporting sponsor of TCOYD. Xeris manufactures Gvoke HypoPen (liquid glucagon) for hypoglycemia and partnered on educational content about glucagon options and emergency hypoglycemia management.
• Eversense (Ascensia)supportingGTM or Marketing PartnerSupporting sponsor of TCOYD. Eversense makes the Eversense E3 implantable CGM (365-day wear).
• InsuletsupportingGTM or Marketing PartnerSupporting sponsor of TCOYD. Insulet manufactures the Omnipod tubeless insulin pump.
• GenentechsupportingGTM or Marketing PartnerSupporting sponsor of TCOYD. Genentech manufactures Lucentis and Vabysmo for diabetic eye disease.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Diabetes Daily: Online diabetes community and education platform serving people with all diabetes types. Comparable as a free, content-led diabetes education site serving both patients and caregivers.
• The diaTribe Foundation (dQ&A): Nonprofit diabetes education and patient-advocacy organization producing content across T1D, T2D, obesity, and diabetes tech. Closest direct peer — same patient-education mission, pharma-supported model, and focus on diabetes technology and treatment literacy.
• Beyond Type 1: Nonprofit producing diabetes education content, community programs, and resources, primarily for T1D. Comparable in mission (education + advocacy), digital content distribution, and pharma/device sponsor support model.

Broad incumbents

• JDRF (formerly Juvenile Diabetes Research Foundation): Large, established T1D-focused nonprofit spanning research funding, advocacy, and patient education. Comparable mission overlap on T1D education, but broader scope (research grants, government advocacy) and significantly larger scale than TCOYD.
• American Diabetes Association: National umbrella nonprofit for diabetes providing professional education, standards of care, advocacy, and patient resources. Comparable in diabetes education mission but operates at vastly larger scale across all-diabetes-types with clinical guideline authority.

Regional players

• Diabetes UK: UK-based national diabetes charity providing patient education, support services, and research funding. Comparable nonprofit diabetes education model, but operating primarily in the UK and Ireland rather than the US market TCOYD serves.

Others

• Insulet (Omnipod) / Dexcom / Abbott patient education programs: Diabetes device manufacturers whose patient-education portals (pod start training, CGM onboarding, FreeStyle Library) compete for the same patient/HCP attention. Listed as they are partial sponsors of TCOYD while also operating overlapping education assets.

Emerging players

• Diabetes Strong: Smaller-scale diabetes education site producing articles, recipes, and exercise guidance for people with diabetes. Comparable content focus (lifestyle, nutrition, exercise education) but operates at a smaller editorial scale without events or CME programming.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/TCOYD
• YouTubeyoutube.com/freestyleus
• Facebookfacebook.com/323847085675
• Instagraminstagram.com/freestylediabetes
• LinkedInlinkedin.com/company/taking-control-of-your-diabetes

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TCOYD